株式会社TearExo
Kobe, JP · 1 known investors
TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.
Investors · 1
Frequently asked questions
- What does 株式会社TearExo do?
- TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.
- Who are 株式会社TearExo's investors?
- 株式会社TearExo's investors include Kobe University Capital.
- Where is 株式会社TearExo headquartered?
- 株式会社TearExo is headquartered in Kobe, JP.